82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 11.93

Change

-0.06 (-0.50)%

Market Cap

USD 8.59B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.92 (+4.04%)

USD 145.11B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+3.60 (+4.23%)

USD 28.00B
2801:HK iShares Core MSCI China ETF

+1.10 (+4.76%)

USD 18.24B
2823:HK iShares FTSE A50 China

+0.20 (+1.47%)

USD 17.22B
83188:HK ChinaAMC CSI 300 Index ETF

+0.58 (+1.43%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.09 (+6.34%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.75 (+6.51%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

+0.13 (+1.71%)

USD 3.03B
9846:HK iShares Core CSI 300

+0.06 (+1.67%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.89% 41% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.89% 41% F 46% F
Trailing 12 Months  
Capital Gain 10.46% 58% F 63% D
Dividend Return 2.96% 44% F 25% F
Total Return 13.43% 60% D- 64% D
Trailing 5 Years  
Capital Gain -9.89% 41% F 71% C-
Dividend Return 11.78% 73% C 37% F
Total Return 1.89% 52% F 70% C-
Average Annual (5 Year Horizon)  
Capital Gain -4.72% 48% F 46% F
Dividend Return -2.50% 53% F 47% F
Total Return 2.22% 66% D+ 75% C
Risk Return Profile  
Volatility (Standard Deviation) 15.68% 64% D 85% B
Risk Adjusted Return -15.93% 54% F 45% F
Market Capitalization 8.59B 73% C 83% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike